A report from the US Federal Trade Commission (FTC) shows how pharmacy benefit managers in the USA are overcharging patients for cancer medicines and shifting dispensing of cancer drugs to their own affiliated pharmacies for profit, ultimately restricting patients’ access to quality cancer treatment and jeopardising their lives.
[News] Impact of pharmacy benefit managers on cancer health care
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
LATEST
Sign up for our emails
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Newsletter
Privacy Policy